The company is developing a CE-certified e-health platform with e-treatments (digital treatments) for specific drugs and cancer treatments. ScientificMed aims to significantly improve the outcome of its treatment with cancer drugs by providing digital tools and services for healthcare professionals and patients. The company, together with pharmaceutical companies, healthcare providers and Karolinska Institutet, has carried out several clinical studies and evaluation projects with positive results. The company was acquired by Cuviva in 2021.